semaglutide for autoimmune disease Do Anti-Obesity Medications Benefit Diseases? Association between autoimmune diseases and

Single vial tirzepatide (Zepbound) rollout Eli Lilly has launched single dose vials of tirzepatide (Zepbound) a dual GLP-1/GIP agonist approved for obesity and sleep apnea treatmentoffering a more accessible and flexible self-pay option

doi:10.1038/nri.2016.111 Gocki J, Bartuzi Z

The FDA has declared the shortages as resolved," removing the drugs from its shortage list

Clear diagnosis: A simple blood test can accurately pinpoint specific electrolyte deficiencies or excesses

They identified immature cardiomyocytes that enter the cell cycle following injury and disappear as the heart loses its regenerative ability

Some evidence suggests that glutathione skin whitening may be effective